- Report
- February 2026
- 455 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 181 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 173 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 259 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 246 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 233 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- May 2025
- 130 Pages
Global
From €4155EUR$4,750USD£3,585GBP
- Report
- August 2025
- 145 Pages
Global
From €3455EUR$3,950USD£2,981GBP
- Report
- June 2025
- 144 Pages
Global
From €3455EUR$3,950USD£2,981GBP
- Report
- July 2025
- 350 Pages
Global
From €4329EUR$4,949USD£3,735GBP
- Report
- June 2025
- 400 Pages
Global
From €4329EUR$4,949USD£3,735GBP
- Report
- June 2025
- 225 Pages
Global
From €4369EUR$4,995USD£3,770GBP
- Report
- October 2025
- 160 Pages
Global
From €3455EUR$3,950USD£2,981GBP
- Report
- September 2025
- 112 Pages
Global
From €3500EUR$4,287USD£3,126GBP
- Report
- October 2025
- 150 Pages
Global
From €3367EUR$3,850USD£2,906GBP
€4242EUR$4,850USD£3,660GBP
- Report
- February 2025
- 150 Pages
Global
From €3367EUR$3,850USD£2,906GBP
€4242EUR$4,850USD£3,660GBP
- Report
- March 2025
- 138 Pages
Global
From €4242EUR$4,850USD£3,660GBP
- Report
- February 2025
- 100 Pages
Europe
From €5204EUR$5,950USD£4,490GBP
- Report
- June 2025
United States
From €2143EUR$2,450USD£1,849GBP
- Report
- December 2022
- 325 Pages
Global
From €4738EUR$5,607USD£3,950GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more